CES continued to maintain a prudent approach to capital spending through the quarter with CapEx spend net of disposal proceeds of $24,000,000 We will continue to adjust plans as required to support existing business and attractive growth throughout our divisions. And for full year 2024, we expect cash CapEx to be approximately $85,000,000 weighted more towards specific expansion capital to support incremental accretive business development opportunities and also to support current record revenue levels. Looking forward, we expect this level to decline back to the $70,000,000 to $80,000,000 range and estimate that to come in at about $75,000,000 for 2025. During the quarter, we aggressively pursued our current NCIB program, purchasing 6,000,000 common shares at an average price of $7.67 per share for a total cash outlay of $46,000,000 Subsequent to September 30, the company purchased an incremental 3,300,000 common shares at an average price of $7.76 per share for a total of $25,600,000 Year to date, we purchased almost 14,000,000 shares, representing 6% of outstanding shares as at December 31, 2023, at an average price of $6.44 per share. It should be noted that since inception of the NCIB program on July 17, 2018, this company has purchased 68,000,000 shares, representing 25% of outstanding shares at the time of the inception of the program for an average price of $3.32 per share.